Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02834988 · ClinicalTrials.gov registry record
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 76
- Enrollment target
NCT02834988 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 76 participants.
The verdict
NCT02834988 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The investigators hypothesize that SLND (unlike lymphadenectomy) decreases complications such as hemorrhage, lower extremity lymphedema and lymphocyst formation while enhancing quality of life in EC patients with low risk for nodal involvement. The investigators also hypothesize that SLND is an effective method of staging these patients. Studies have shown that SLN mapping identifies positive lymph nodes in women with newly diagnosed EC and this prognostic information obtained from SLND could guide selection of adjuvant treatment and improve overall survival. Using SLND as an alternative to lymphadenectomy may also have additional medical and economic impacts, such as, decreasing prolonged hospitalization and associated costs by shortening overall surgery duration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-07-28 |
| Est. Completion | 2020-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02834988
The ClinicalTrials.gov registry entry for NCT02834988 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02834988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02834988 about?
NCT02834988 is a clinical study titled "Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer". The investigators hypothesize that SLND (unlike lymphadenectomy) decreases complications such as hemorrhage, lower extremity lymphedema and lymphocyst formation while enhancing quality of life in EC patients with low risk for nodal involvement. The investigators also hypothesize that SLND is an eff...
What is the current status of trial NCT02834988?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2016-07-28. Estimated completion is 2020-02-10.
Who is sponsoring clinical trial NCT02834988?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.